BioSpace News Archive

Policy

With Illumina Acquisition Pending, GRAIL Presents Multi-Cancer Detection Test

Grail presents its first data from the interventional PATHFINDER trial of Galleri, its multi-cancer early detection blood test. Galleri is now available in the U.S. by prescription.

June 7, 2021
·
3 min read
·
Mark Terry
Policy

Merck Investigating Noose Reportedly Found at Durham, North Carolina Plant

An ugly symbol of racism appears to have reared its head at a Merck facility in North Carolina. The pharma giant is investigating reports of a noose found hanging at a construction project on the 262-acre facility.

June 7, 2021
·
2 min read
·
Alex Keown
FDA

United Therapeutics Now Suing Liquidia for Trade Secret Misappropriation

United claims Liquidia and a former employee misappropriated its trade secrets such as regulatory submissions and detailed financial forecasts for its inhaled treprostinil.

June 7, 2021
·
2 min read
·
Brandon May
Drug Development

Biogen’s Aducanumab First Alzheimer’s Drug Approved in Nearly 20 Years

The U.S. Food and Drug Administration granted approval of Biogen’s aducanumab for the treatment of Alzheimer’s disease.

June 7, 2021
·
3 min read
·
Mark Terry
Drug Development

AstraZeneca Redefining Cancer Care in Breast Cancer, Leukemia at ASCO

After three years, 85.9% of patients treated post-surgically with Lynparza were free of invasive breast cancer and second cancers compared to 77.1% of the placebo group.

June 7, 2021
·
3 min read
·
Heather McKenzie
Drug Development

ASCO 2021: Fate Therapeutics Stock Jumps on Positive Data from Lymphoma Study

Shares of Fate climbed nearly 4% in premarket trading after it announced positive interim data from a Phase I study of FT516 for patients with relapsed / refractory B-cell lymphoma.

June 7, 2021
·
4 min read
·
Alex Keown
Drug Development

FDA Lifts Hold on bluebird bio’s Sickle Cell and Beta-Thalassemia Gene Therapies

The FDA lifted the clinical holds on bluebird bio’s sickle gene therapy and its betibeglogene autotemcel gene therapy for adults, adolescents and children with TDT.

June 7, 2021
·
3 min read
·
Mark Terry
Near Infrared Imaging Market: Increasing Number of Surgical Procedures across the world

The market is estimated to grow with a CAGR of 4.2% from 2020 to 2027.

June 7, 2021
·
5 min read
Drug Development

Novartis Showcases Multiple Clinical Programs At ASCO

Novartis flexed its clinical muscles over the weekend, announcing results from multiple studies including different types of cancer and kidney disease.

June 7, 2021
·
4 min read
·
Alex Keown
Business

Argenx Regains Rights to Blood Cancer Drug Following Dropped $1.6 Billion Deal

As a result of the termination, argenx will regain worldwide rights to cusatuzumab, its anti-CD70 antibody, from Cilag FmbH International, one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

June 7, 2021
·
2 min read
·
Ellen Bombela